Sellas Life Sciences Group Inc
(SLS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Operating Expenses | 17,510 | 7,050 | 11,400 | 0 | 0 |
| Operating Income | -17,510 | -7,050 | -11,400 | N/A | N/A |
| Interest Expense | 5 | 0 | 0 | 0 | 0 |
| Other Income | -865 | 0 | 440 | 0 | 0 |
| Pre-tax Income | -18,380 | -7,050 | -10,960 | 0 | 0 |
| Income Tax | 0 | N/A | 20 | N/A | N/A |
| Net Income Continuous | -18,387 | -14,373 | -10,990 | N/A | N/A |
| Net Income | $-18,380 | $-14,373 | $-10,990 | $N/A | $N/A |
| EPS Basic Total Ops | -37,237.23 | -32,732.73 | -29,729.73 | N/A | N/A |
| EPS Basic Continuous Ops | -36,774.00 | -35,932.50 | -27,475.00 | N/A | N/A |
| EPS Diluted Total Ops | -37,237.23 | -32,732.73 | -29,729.73 | N/A | N/A |
| EPS Diluted Continuous Ops | -36,774.00 | -35,932.50 | -27,475.00 | N/A | N/A |
| EBITDA(a) | $-17,350 | $-6,720 | $-11,370 | $N/A | $N/A |